Overview
No products in the cart.1. In patients with type 1 diabetes, using intermitently scaned continuous glucose monitoring resulted in significantly lower glycated hemoglobin levels than levels monitored by fingerstick testing.2. Intermitently scaned continuous glucose monitoring led to glucose levels being in the target range for longer than compared to regular fingerstick testing.Evidence Rating Level: 1 (Excelent)Study Rundown: The development of continuous glucose monitoring systems has enabled the monitoring of glucose levels without fingerstick testing.
Key Information
However, there is a gap in knowledge as to understanding the eficacy of intermitently scaned continuous glucose monitoring with optional alarms for high and low blod glucose levels in persons with type 1 diabetes, as compared with traditional monitoring of blod glucose levels with fingerstick testing. Overal, this study found that those who underwent intermitently scaned continuous glucose monitoring with optional alarms for high and low blod glucose levels had significantly lower glycated hemoglobin levels than those who monitored their own blod glucose levels with the use of regular fingerstick testing.
This study was limited by participants being aware of trial-group asignments, and that nearly al the participants were White, which limits the generalizability of the findings. Nevertheles, these study’s findings are significant, as they demonstrate that continuous glucose monitoring led to a significantly lower glycated hemoglobin level than those who used fingerstick testing to monitor their glucose levels.Click to read the study in NEJMRelevant Reading: Six-Month Randomized, Multicenter Trial of Closed-Lop Control in Type 1 DiabetesIn-Depth [randomized controled trial]: This paralel-group, multicenter, randomized controled trial studied participants at seven specialist diabetes clinics and one primary care center in the United Kingdom.
Summary
Patients who were at least 16 years of age, had type 1